NRX PHARMACEUTICALS INC's ticker is NRXPW and the CUSIP is 629444118. A total of 6 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,372 | -68.0% | 17,129 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $4,282 | +38.9% | 17,129 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,083 | -28.0% | 17,129 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,284 | -14.3% | 17,129 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | +150.0% | 17,129 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -86.7% | 17,129 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $15,000 | -68.8% | 17,129 | -34.2% | 0.00% | -66.7% |
| Q4 2021 | $48,000 | -65.5% | 26,048 | -10.3% | 0.01% | -72.7% |
| Q3 2021 | $139,000 | -4.1% | 29,048 | -28.6% | 0.02% | -8.3% |
| Q2 2021 | $145,000 | – | 40,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 17,129 | $1,372 | 0.00% |
| UBS Group AG | 7,812 | $625 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 600 | $48 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,426 | $995 | 0.00% |
| Tower Research Capital LLC (TRC) | 15 | $1 | 0.00% |